241 related articles for article (PubMed ID: 2999772)
1. High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells.
Zachary I; Rozengurt E
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7616-20. PubMed ID: 2999772
[TBL] [Abstract][Full Text] [Related]
2. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
Woll PJ; Rozengurt E
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin.
Brown KD; Laurie MS; Littlewood CJ; Blakeley DM; Corps AN
Biochem J; 1988 May; 252(1):227-35. PubMed ID: 2844145
[TBL] [Abstract][Full Text] [Related]
4. Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides.
Sinnett-Smith J; Lehmann W; Rozengurt E
Biochem J; 1990 Jan; 265(2):485-93. PubMed ID: 2154190
[TBL] [Abstract][Full Text] [Related]
5. A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells.
Zachary I; Rozengurt E
Biochem Biophys Res Commun; 1986 May; 137(1):135-41. PubMed ID: 2424443
[TBL] [Abstract][Full Text] [Related]
6. Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. Distinction from acute desensitization.
Millar JB; Rozengurt E
J Biol Chem; 1990 Jul; 265(20):12052-8. PubMed ID: 2164025
[TBL] [Abstract][Full Text] [Related]
7. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Reile H; Armatis PE; Schally AV
Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
[TBL] [Abstract][Full Text] [Related]
8. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
9. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
10. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
[TBL] [Abstract][Full Text] [Related]
11. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
12. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a bombesin receptor on Swiss mouse 3T3 cells by affinity cross-linking.
Sinnett-Smith J; Zachary I; Rozengurt E
J Cell Biochem; 1988 Dec; 38(4):237-49. PubMed ID: 2853712
[TBL] [Abstract][Full Text] [Related]
14. Internalization and degradation of peptides of the bombesin family in Swiss 3T3 cells occurs without ligand-induced receptor down-regulation.
Zachary I; Rozengurt E
EMBO J; 1987 Aug; 6(8):2233-9. PubMed ID: 2822383
[TBL] [Abstract][Full Text] [Related]
15. Identification of a receptor for peptides of the bombesin family in Swiss 3T3 cells by affinity cross-linking.
Zachary I; Rozengurt E
J Biol Chem; 1987 Mar; 262(9):3947-50. PubMed ID: 3031056
[TBL] [Abstract][Full Text] [Related]
16. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
[TBL] [Abstract][Full Text] [Related]
17. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
18. Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding.
Zachary I; Sinnett-Smith JW; Rozengurt E
J Cell Biol; 1986 Jun; 102(6):2211-22. PubMed ID: 3011811
[TBL] [Abstract][Full Text] [Related]
19. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
20. The release of bombesin-like peptides from small cell lung cancer cells.
Moody TW; Korman LY
Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
